Status: Recruiting
A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults
A Phase 1, single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacodynamics of single and multiple dose regimens of SYNT-101 in healthy and overweight adults.
Participants needed: 64
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Syntis BioUpdated: Apr 29, 2026Locations: 1
Eligibility criteria
Must be able to understand the full nature and purpose of the study, including p... [+4]
Known hypersensitivity to the study drug or any of the study drug ingredients. [+2]